Arksa Pharma Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2023.
2023 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Arksa Pharma Private Limited

Arksa Pharma Private Limited, a active private limited company, was established on 09 March 2023 in Mumbai, Maharashtra, India. it holds CIN: U46497MH2023PTC398578. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Gordon Paul Denoronha (Nominee Director), Krasia Gordon De Noronha (Director), Reshma Gordon Noronha (Director). It is based at 3Rd Floor, Sharaf Manzil,, 650 J S S Road, New Marinelines, Mumbai, Maharashtra, 400002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MH2023PTC398578

  • Registration Number

    398578

  • Incorporation Date

    09 March 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 4 Days
Company report

Arksa Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Arksa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Arksa Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Gordon Paul Denoronha Nominee Director 09 Mar 2023 Current
Krasia Gordon De Noronha Director 18 Dec 2023 Current
Reshma Gordon Noronha Director 09 Mar 2023 Current
Ruark Gordon Denoronha Managing Director 09 Mar 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arksa Pharma.

Enhance accessibility to Arksa Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Arksa Pharma revenue growth over time
Arksa Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arksa Pharma?

Unlock access to Arksa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Arksa Pharma?

Unlock and access historical data on people associated with Arksa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arksa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arksa Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arksa Pharma
Recent Activity within the Organization
  • Director Appointment

    Krasia Gordon De Noronha was appointed as a Director was appointed as a Director on 18 Dec 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

  • Director Appointment

    Gordon Paul Denoronha was appointed as a Nominee Director was appointed as a Nominee Director on 09 Mar 2023 & has been associated with this company since 3 years 4 days . was recorded as a recent event.

  • Director Appointment

    Reshma Gordon Noronha was appointed as a Director was appointed as a Director on 09 Mar 2023 & has been associated with this company since 3 years 4 days . was recorded as a recent event.

  • Director Appointment

    Ruark Gordon Denoronha was appointed as a Managing Director was appointed as a Managing Director on 09 Mar 2023 & has been associated with this company since 3 years 4 days . was recorded as a recent event.

  • Company Incorporation

    Arksa Pharma Private Limited was registered on 09 Mar 2023 with Roc Mumbai & aged 3 years 4 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Arksa Pharma Private Limited?

The CIN of Arksa Pharma Private Limited is U46497MH2023PTC398578.

Where is Arksa Pharma Private Limited headquartered?

Arksa Pharma Private Limited is headquartered at 3Rd Floor, Sharaf Manzil,, 650 J S S Road, New Marinelines, Mumbai, Maharashtra, 400002.

When was Arksa Pharma Private Limited incorporated?

Arksa Pharma Private Limited was incorporated on 09 March 2023.

Who are the current directors of Arksa Pharma Private Limited?

The current directors of Arksa Pharma Private Limited are

Is Arksa Pharma Private Limited a listed company?

Arksa Pharma Private Limited is unlisted.

What is the capital structure of Arksa Pharma Private Limited?

The authorized capital of Arksa Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available